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Small molecular weight hormones such as prostaglandin E  (PGE) and histamine, 
would appear to have a role in the regulation of cellular immune function. Evidence 
for  this  is  as  follows.  PGE1  or  E2  added  in  low  concentrations  (10-9-10  -6  M)  to 
mitogen-stimulated cultures of human peripheral blood mononuclear cells  (PBMC) 
or T  cells causes inhibition of proliferation as measured by [ZH]thymidine incorpo- 
ration (1, 2) or by cell numbers (3). PGE2 is produced in mitogen-stimulated cultures 
of human  PBMC  (1,  2)  and  mouse  splenocytes  (4).  Blockade of PG  synthesis  in 
mitogen-stimulated cultures by addition of various PG synthetase inhibitors results in 
an increase in  [3H]thymidine incorporation and in cell numbers (3).  Administration 
of PG synthetase inhibitors in vivo also results in an enhanced delayed hypersensitivity 
skin test reponse in man (5) and in experimental animals (6). 
A  role  for  histamine  in  immunoregulation  is  suggested  by  the  appearance  of 
histamine  receptors  on  activated  T  lymphocytes  (7).  These  T  cells,  which  bear 
receptors for histamine, act as suppressor cells in several systems (8-10). 
We  have  recently demonstrated  high-affinity binding  sites  for PGE2  on  human 
lymphocytes (11,  12). We have also confirmed earlier reports (13)  that cyclic AMP is 
the  second  messenger  for PGE2  in  lymphocytes (12).  The cyclic AMP  response to 
PGE2  and  histamine  provides  a  sensitive  assay  which  indicates  the  presence  of 
receptors for these compounds (12,  13). 
In  this report  we  show  that  the  cyclic AMP  response  to  PGE2  is  not  equally 
distributed among lymphocytes. It would appear that both B and T  cells respond to 
PGE2, but among T  cells, only those that bear a  receptor for the Fc portion of IgG 
(Ty cells) respond to PGE2 with a cyclic AMP increase. 
Materials and Methods 
Isolation  of Mononuclear Cells.  Heparinized  peripheral  venous  blood  was  obtained  from 
healthy donors.  Mononuclear cells were  isolated on  a  Ficoll-Hypaque density gradient  (14) 
(Pharmacia Fine Chemicals, Piscataway, N. J.). Glass adherent cells were removed by incuba- 
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tion at 37°(3 for 30 min in glass Petri dishes. Glass nonadherent cells were washed three times 
with Hanks' balanced salt solution (HBSS)  and resuspended at 4 ×  106 cells per milliliter in 
RPMI-1640 medium plus 20% fetal calf serum (absorbed with sheep erythrocytes [sRB(2]). 
Isolation and Purification of T  Lymphocytes.  Equal  volumes of glass  nonadherent cells  were 
mixed with 1% neuraminidase-treated  sRBC (10 IU neuraminidase per 1 ml of 5% sRBC). The 
mixture was incubated for  10 rain at 37°C, centrifuged for 5 min at 200 g, and then incubated 
for  1 h at 4°C. After incubation, the pellets were resuspended gently using a wide bore pipette. 
Rosetting T  cells  were  purified  from  nonrosetting cells  on  a  FicolI-Hypaque gradient  by 
centrifugation for  20  min at  480 g  in room temperature.  Sheep  RBC were lysed with Tris~ 
NH4CI  buffer. Cells from the bottom were washed three times in HBSS and were  shown to 
contain 96-98% T  cells as determined by rerosetting with sRBC and lack of surface immuno° 
globulins as identified by immunofluorescence using rabbit F(ab')2 anti-human Ig.  Viability 
was >98% as judged by trypan blue dye exclusion. Cells at the interface, termed non-T cells, 
were composed of 50-60% cells bearing surface immunoglobulin  and 15-25% E-rosetting cells. 
Isolation of  7"7  Lyrnphoeytes.  Ty  cells  were  isolated  on  the  same  day  by  using  bovine 
erythrocytes coated with the IgG fraction of rabbit anti-bovine RBC antibody (N. L. Cappel 
Laboratories, Inc., Cochranville, Pa.).  Bovine RBC-antibody complexes  (EA-IgG) were pre- 
pared according to Gupta and Good (15) by incubating  equal volumes of 2% bovine RBC and 
IgG antibody (1:200) at room temperature for 90 min. The complexes were washed three times 
with  HBSS  and resuspended to  1%  in RPMI-1640 medium. Purified T  cells  (4  ×  10  s per 
milliliter in RPMI-1640) were mixed with equal volumes of 1% EA-IgG, centrifuged at 200 g 
for  5  min, and  incubated for  60  min at  4°(2.  The  pellets were  resuspended using Pasteur 
pipettes, layered over a FicolI-Hypaque gradient and centrifuged at 400 g for 20 min in room 
temperature. Greater than 96% of the cells at the bottom rosetted with EA-IgG; 2-4% of the 
cells at the interface rosetted with EA-IgG. Bovine RBC were  lysed using Tris-NH4CI buffer. 
Drugs.  PGE2 was a  gift  of Dr. John Pike (The Upjohn Co., Kalamazoo, Mich.) and was 
dissolved in 95% ethyl alcohol with a final ethanol concentration in the incubation medium of 
_<0.001'~. 0.01%  ethanol had  no effect  on the cyclic AMP response of control incubations. 
Histamine (Sigma Chemical Co., St. Louis, Mo.)  was dissolved  in HBSS. 
Generation of Cyclic AMP.  Each lymphocyte fraction was resuspended at a final concentration 
of 106 per milliliter in minimal essential media (Microbiological Associates, Walkersville, Md.) 
with  10% fetal calf serum (Grand Island Biological  (2o., Grand Island, N. Y.)  supplemented 
with  L-glutamine and  penicillin-streptomycin. 1-ml  aliquots  of  the  cell  suspensions were 
incubated in  polypropylene tubes  (2063,  Falcon  Labware,  Div.  Becton,  Dickinson &  Co., 
Oxnard, (2a.) at 37°C with 5% (202  for 60 min. Drugs were then added and reactions were 
stopped  after  5  min additional incubation. Preliminary experiments showed  that  a  5-min 
incubation period gave maximal cyclic AMP responses for both prostaglandin E2 and histamine 
when no phosphodiesterase inhibitor was present in the incubation mixture. 
Incubations were stopped by centrifugation at 4°C at 400 g for 5 min. After centrifugation, 
the supernates were decanted and the tubes were blotted against absorbent material. The cells 
were  resuspended in  1 ml of cold Na acetate, 50 mM, pH 6.2, vortexed, and frozen in liquid 
nitrogen for 5 min. The tubes were then placed in a boiling water bath for 5 min. The resultant 
cell  debris was  removed by centrifugation at  2,000  g  for  20  min, and the supernates were 
assayed for cyclic  AMP content using an acetylation method as described by Frandsen and 
Krishna (16). All lymphocyte incubations were prepared in duplicate. Duplicates of each were 
assayed for cyclic AMP. 
Results and  Discussion 
Table I  presents data from three normal subjects on the cyclic AMP response of 
lymphocytes to  PGE2 and histamine. Unfractionated lymphocytes, T-cell-enriched, 
T-cell-depleted, TT, and non-T,/fractions all show a substantial cyclic AMP increase 
after exposure to PGE at  10  -n M. The cyclic AMP response of the T  cells to  PGE2 
would appear to be concentrated in the T7 fraction. The T-cell fraction, of which 11- 
18%  were Ty cells, had a  10.8-fold increase in cyclic AMP after exposure to PGE2. 
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TABLE  I 
Cyclic AMP Response to PGE2 and Histamine in Human Lymphocytes and Lymphocyte Subfractions 
Base-line 
Cells tested  cyclic AMP 
PGE2 10  -6 M  Histamine 10  -4 M 
Cyclic AMP  SI*  Cyclic AMP  SI* 
fmol/ lO 6 cells  fmol/ lO 6 cells  fmol/ lO 6 cells 
Lymphocytes  2,485 +  760  31,160 ±  6,830  12.8 ±  3.8  3,510 ±  1,095  1.4 ±  0.2 
T-depleted  4,955 ±  1,440  51,250 ±  10,910  11.8 ±  1.5  9,255 ±  2,740  1.8 ±  0.2 
T-enriched  2,620 :t: 440  29,120 ±  8,035  10.8 :t: 2.2  3,405 ±  900  1.2 ±  0.3 
T T  2,460±860  64,975±21,335  27.4±3.2  2,110±400  1.0±0.2 
Non-T  T  1,065 ±  240  4,365 ±  1,510  4.0 :t: 1.6  720 ±  140  0.7 :t: 0.4 
Data are from three experiments on  different individuals. The cyclic AMP  values are the mean ±  standard error in 
fmol/106 cells. Each incubation was done in duplicate, and the cyclic AMP determination was also in duplicate. 
* SI,  stimulation  index.  Data  for  SI  are  given as  mean  :tz  standard  error of the  indi'~idual  stimulation  indices.  The 
stimulation  indices  for the lymphocyte, T-depleted, and T-enriched fractions  after PGE2 are not  different  from one 
another (P >  0.5). The SI for TT is significantly greater (P <  0.001), and the SI for the non-T'/is significantly smaller 
(P <  0.01) than the Sis for the lymphocyte, T-depleted, or T-enriched fractions after PGE2. 
whereas the T  cells remaining after enrichment for T T had only a fourfold increase in 
cyclic AMP. The mean absolute increase in cyclic AMP content after PGEz stimula- 
tion was  19 times higher in the Ty than in the non-T  T fraction. Because the non-T  T 
fraction still  had  2-4% T T cells,  the small  cyclic AMP increase seen  in  the  non-T  T 
fraction could be almost entirely explained by the contaminating TT cells. 
The  cyclic  AMP  response  of the  lymphocyte  fractions  to  histamine  was  more 
modest.  A  small  but  significant  rise  in  cyclic  AMP  occurred  in  the  response  of 
unfractionated lymphocytes to histamine.  The non-T-cell fraction also had a  small 
response, whereas the T-enriched, TT, and non-Ty fractions showed no cyclic AMP 
response  to  histamine.  These  studies  were  performed without  a  phosphodiesterase 
inhibitor in  the cell suspensions.  When  10  -4 M  3-isobutyl-l-methylxanthine, a  pow- 
erful phosphodiesterase inhibitor, was added to the suspensions before the addition of 
histamine,  there  was  a  small  but  significant  increase  in  cyclic AMP  in  the  T-cell 
fraction  (stimulation  index of 4.4  +  1.2) with similar increases in both the TT and 
non-T  T fractions  (3.1  +  0.6  and  3.6  __.  0.8,  respectively). Our finding of a  lack of 
histamine receptors on unstimulated lymphocytes is in agreement with the findings of 
previous investigations (1, 5). Interestingly, the weak cyclic AMP response to histamine 
in the presence of a phosphodiesterase inhibitor was not concentrated in any lympho- 
cyte subfraction. 
It is possible that the binding or activation of the Fc receptors of the T  ceils during 
the isolation procedure rendered the cells  more sensitive to PGE2. To test  for this we 
added  EA-IgG to  T-cell  suspensions  and  measured  the  effect  on  the  cyclic AMP 
response  of these  T  cells  to  PGEs  In  three  experiments,  the  stimulation  index  for 
cyclic  AMP  after  exposure  to  10  -8  M  PGE2  was  9.4  +  2.1  for  the  T  Cells; this 
increased  to  14.8  +  1.8  for the T  cells  plus bovine EA-IgG. Thus,  not only are T7 
cells  responsible for the cyclic AMP increase to PGEz in T  cells,  but the TT cells  are 
further sensitized to PGE2 by activation of their Fc receptors.  It was not possible to 
measure  the  cyclic AMP  response  of TT  cells  to  PGE  without  activating  the  Fc 
receptors. The negative isolation technique of enriching for TT cells  by rosetting T/I 
cells (those T  cells  with an Fc receptor for IgM) involves an incubation step of 18 h. 
We have previously shown that lymphocytes lose their response to PGE during such 
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Lymphocytes that are incubated at 37°C for 20 h  lose their sensitivity to PGE2, as 
measured  by suppression of mitogenesis (2),  [sH]PGE binding  (11),  or cyclic AMP 
response (12).  Because the T 7 cells are the T  cells that respond to PGE with a cyclic 
AMP increase, we examined whether the loss of cyclic AMP response to PGE2 with 
preincubation was a result of a loss of T 7 cells. In three experiments, incubation of T 7 
cells  for  20  h  at  37°C  before exposure  to  PGE2  resulted  in  a  loss  of cyclic AMP 
response to  10  -~ M  PGE2  (stimulation index of 27.4  __.  3.2  before incubation  vs.  3.4 
_+  0.8  after  incubation).  This  loss  of cyclic  AMP  response  was  paralleled by  the 
disappearance of the T 7 cells from the cultures. Before incubation, >90% of the cells 
in  the  T7  fraction  formed  rosettes  with  EA-IgG.  After  20  h  of  incubation,  this 
percentage decreased to 20 2:  1%. Thus, the loss of sensitivity of lymphocytes to PGE 
with preincubation may be a result of a loss of T 7 cells. 
The localization of the cyclic AMP response to PGE on only a  small fraction of 
peripheral blood T  cells suggests new possibilities for how PGE suppresses the T-cell 
response to mitogens. We have previously shown that PGE will inhibit [SH]thymidine 
incorporation  in  phytohemagglutinin-  or  concanavalin  A-stimulated  T  cells  by as 
much as 90% (1).  Because >50% of circulating T  cells proliferate in response to these 
mitogens (17), it is difficult  to postulate that PGE is directly suppressing the prolif- 
erative response of each T  cell in light of our finding that only a small proportion of 
these cells appear to bear PGE receptors.  It  is  possible that  PGE  activates the  T 7 
population to suppress the proliferative response of the non-T  7 cells. Such a  mecha- 
nism of PGE activation of suppressor cell function has previously been suggested by 
Webb and Nowowiejski in mouse splenocytes (4). 
Summary 
Receptors for prostaglandin  E2 or histamine were measured on subpopulations of 
human lymphocytes, using the cyclic AMP increase after exposure to prostaglandin 
or histamine as an indicator for the presence of receptors. The cyclic AMP response 
to prostaglandin  E2 was similar in  unfractionated  lymphocytes and  the T-enriched 
and T-depleted fractions. Within the T-enriched population, T cells bearing a receptor 
for the Fc portion of IgG 0"7 cells) had a 27.4-fold rise in cyclic AMP after exposure 
to  prostaglandin  E2,  whereas  the  remaining T  cells  (non-T'}, cells)  had  a  fourfold 
increase. It would  appear that  prostaglandin  receptors are concentrated  on a  small 
subfraction of T 7 cells, comprising ~ 15% of the T-cell population.  The cyclic AMP 
response to histamine was <twofold in all lymphocyte fractions. 
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